BP
ATHN

Ballentine Partners’s Athenahealth, Inc. ATHN Stock Holding History

Ballentine Partners’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-28,165
Closed -$3.76M – 397
2018
Q3 		$3.76M Sell
28,165
-3,600
-11% -$539K 0.2% 47
2018
Q2 		$5.05M Sell
31,765
-13,500
-30% -$2M 0.28% 36
2018
Q1 		$6.47M Hold
45,265
– – 0.36% 30
2017
Q4 		$6.02M Buy
45,265
+42,862
+1,784% +$5.48M 0.33% 34
2017
Q3 		$299K Hold
2,403
– – 0.02% 269
2017
Q2 		$367K Buy
+2,403
New +$300K 0.03% 243

Other funds holding ATHN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Ballentine Partners's ATHN Position: Q4 2018 in Review

Ballentine Partners sold out of Athenahealth, Inc. (ATHN) in Q4 2018, closing a stake of 28,165 shares — an estimated $3.76M sold.

Ballentine Partners first reported a position in ATHN in Q2 2017 and held it in 6 quarters. The position peaked at $6.47M in Q1 2018. 263 funds tracked by Wall St. Rank hold ATHN as of Q4 2018.

  • Ballentine Partners reported no remaining Athenahealth, Inc. position as of Q4 2018 after selling out during the quarter.
  • Ballentine Partners sold 28,165 Athenahealth, Inc. shares in Q4 2018, an estimated $3.76M.
  • Ballentine Partners first reported a position in Athenahealth, Inc. in Q2 2017 and held it in 6 quarters.
  • Ballentine Partners's Athenahealth, Inc. position peaked at $6.47M in Q1 2018.
  • 263 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2018.

Based on Ballentine Partners's 13F filing for Q4 2018, filed 4 Feb 2019.